基本信息
浏览量:45
职业迁徙
个人简介
Professor Lora Heisler holds a Chair in Human Nutrition at the Rowett Institute, University of Aberdeen. Professor Heisler’s laboratory investigates brain circuits regulating energy balance and glucose homeostasis in an effort to identify new targets amenable to obesity and type 2 diabetes pharmacotherapy. Professor Heisler was awarded her PhD from Tufts University, USA with supervisor Professor Robin Kanarek in 1997 where she investigated repurposing selective serotonin reuptake inhibitor Prozac for obesity treatment. Postdoctoral positions were held at the University of California, San Francisco USA with Professor Larry Tecott from 1997-1999 and then Beth Israel Deaconess Medical Center, Harvard Medical School USA with Professor Joel Elmquist from 1999-2001 where Professor Heisler discovered the therapeutic mechanism underpinning global obesity medication d-fenfluramine. In 2001, Professor Heisler was promoted to Instructor at Harvard Medical School and began her independent laboratory. Professor Heisler moved her group to the University of Cambridge, UK in 2004 to join the Department of Clinical Biochemistry with Professor Steve O’Rahilly and here she identified a mechanistically novel treatment for type 2 diabetes, a serotonin 5-HT2C receptor agonist. She then obtained a tenured position in the Department of Pharmacology at the University of Cambridge in 2007 where her laboratory continued to pursue the identification of new obesity and type 2 diabetes medications, with an emphasis on serotonin circuits in combination with other pathways. Her discoveries in the first decade of 2000 contributed to the scientific foundation for a new obesity medication now in human use and led to receipt of the Scientific Achievement Award from the Obesity Society in 2011. In 2013, Professor Heisler’s group relocated to the Rowett Institute, where she holds a Chair in Human Nutrition. Professor Heisler was elected to the Royal Society of Edinburgh in 2016. Career contributions identifying new therapeutic targets for obesity and type 2 diabetes medications has been acknowledged through the Outstanding Scientific Achievement Award from the American Diabetes Association in 2018 and recent Plenary/Keynote lectures at annual meetings for the Chinese Diabetes Society (2018), Research for the Study of Diabetes in India (2018), the Physiological Society (2019), British Neuroscience Association (2019), British Society for Neuroendocrinology (2019) and the Society for the Study of Ingestive Behaivor (2019).
研究兴趣
论文共 111 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Alasdair Leeson-Payne,Jean Iyinikkel,Cameron Malcolm,Brian Y. H. Lam,Nadine Sommer,Georgina K. C. Dowsett,Pablo B. Martinez de Morentin,Dawn Thompson,Alasdair Mackenzie,Raffaella Chianese,Katherine Kentistou,Eugene J. Gardner,John R. B. Perry,Felix Grassmann,John R. Speakman,Justin J. Rochford,Giles S. H. Yeo,Fiona Murray,Lora K. Heisler
Frontiers in endocrinology (2024)
Neuropharmacology (2023): 109758-109758
Cameron Malcolm, Jean Iynikel,Alasdair Leeson-Payne, Thomas McSkimming, Anastasios Papadam, Sarak K. Walsh,Felix Grassmann,Dawn Thompson,Lora K. Heisler,Fiona Murray
BRITISH JOURNAL OF PHARMACOLOGY (2023): 656-657
引用0浏览0引用
0
0
PROCEEDINGS OF THE NUTRITION SOCIETYno. OCE1 (2022)
biorxiv(2022)
加载更多
作者统计
#Papers: 111
#Citation: 8250
H-Index: 46
G-Index: 79
Sociability: 6
Diversity: 3
Activity: 28
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn